Patents by Inventor Ashok Katdare

Ashok Katdare has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AMANTADINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20160151307
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: September 23, 2015
    Publication date: June 2, 2016
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • DONEPEZIL COMPOSITIONS AND METHODS OF TREATING ALZHEIMERS DISEASE
    Publication number: 20150216849
    Abstract: Oral dosage forms comprising donepezil or a pharmaceutically acceptable salt thereof (e.g., donepezil hydrochloride) alone or in combination with a second active ingredient (e.g., memantine hydrochloride or a pharmaceutically acceptable salt thereof) for the treatment of Alzheimer's disease are provided. The oral dosage forms comprise donepezil granules that may be sprinkled on food and can significantly improve compliance in patients with swallowing difficulty.
    Type: Application
    Filed: February 4, 2015
    Publication date: August 6, 2015
    Inventors: Mahendra G. Dedhiya, Kavita Vermani, Ashok Katdare
  • AMANTADINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20150057355
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: October 24, 2014
    Publication date: February 26, 2015
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • AMANTADINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20150051292
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: October 24, 2014
    Publication date: February 19, 2015
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • AMANTADINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20150045439
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: October 24, 2014
    Publication date: February 12, 2015
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • AMANTADINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20150045446
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: October 24, 2014
    Publication date: February 12, 2015
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • AMANTADINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20150045447
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: October 24, 2014
    Publication date: February 12, 2015
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • AMANTADINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20150045438
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: October 24, 2014
    Publication date: February 12, 2015
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • AMANTADINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20150045448
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: October 24, 2014
    Publication date: February 12, 2015
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • AMANTADINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20140242163
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: May 1, 2014
    Publication date: August 28, 2014
    Applicant: Adamas Pharmaceuticals, Inc.
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • Method of administering amantadine prior to a sleep period
    Patent number: 8741343
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Grant
    Filed: December 2, 2010
    Date of Patent: June 3, 2014
    Assignee: Adamas Pharmaceuticals, Inc.
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • AMANTADINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20110189273
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: December 2, 2010
    Publication date: August 4, 2011
    Applicant: Adamas Pharmaceuticals, Inc.
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • Effervescent bisphosphonate formulation
    Publication number: 20070087052
    Abstract: An effervescent formulation of alendronate contains an acid source, a carbonate source, a binder, a lubricant and optionally, flavoring agents, colorants and sweeteners.
    Type: Application
    Filed: March 27, 2006
    Publication date: April 19, 2007
    Inventors: Ashok Katdare, Kenneth Kramer, Colin Gardner
  • Compressed tablet formulation
    Publication number: 20060188570
    Abstract: This invention relates to a 50% drug loaded compressed tablet formulation for efavirenz. Efavirenz is a non-nucleoside reverse trancriptase inhibitor being studied clinically for use in the treatment of HIV infections and AIDS.
    Type: Application
    Filed: April 14, 2006
    Publication date: August 24, 2006
    Inventors: Udit Batra, Raymond Higgins, Karen Thompson, Ashok Katdare
  • Effervescent bisphosphonate formulation
    Publication number: 20060034921
    Abstract: An effervescent formulation of alendronate contains an acid source, a carbonate source, a binder, a lubricant and optionally, flavoring agents, colorants and sweeteners.
    Type: Application
    Filed: October 19, 2005
    Publication date: February 16, 2006
    Inventors: Ashok Katdare, Kenneth Kramer, Colin Gardner
  • Method for blinding a medication
    Publication number: 20050084525
    Abstract: An object of the present invention is to provide an improved method for blinding a dosage form such that investigators analyzing such dosage form and subjects ingesting such dosage form cannot determine the identity of the active medication from the placebo they are administering or ingesting. The improved method is termed “overprinting”. In an embodiment, the method for blinding a dosage form comprises printing one or more layers of ink to said dosage form such that the original markings on said dosage form are masked.
    Type: Application
    Filed: September 1, 2004
    Publication date: April 21, 2005
    Inventors: Adeyinka Abinusawa, Abizer Bookwala, Ashok Katdare, Patrick McLaughlin
  • Method for formulating healthcare products with enhanced stability
    Publication number: 20050013924
    Abstract: A method is disclosed for formulating healthcare products, including solid pharmaceutical compositions, while avoiding instability caused ba interaction of the active ingredient with excipients. The method comprises the steps of: (a) selecting an active ingredient that loses stability or potency upon interaction with pharmaceutical excipients; and (b) depositing the active ingredient, preferably electrostatically, as a dry powder substantially free of excipients, onto a pharmaceutically acceptable polymer substrate.
    Type: Application
    Filed: July 6, 2001
    Publication date: January 20, 2005
    Inventors: Ramaswamy Murari, Ashok Katdare, Suggy Chrai, Troy Harmon
  • Ibuprofen lysinate pharmaceutical formulation
    Patent number: 5622990
    Abstract: Pharmaceutical ibuprofen lysinate dry granulation formulations comprising about 90% w/w ibuprofen lysinate are useful for the preparation of tablets containing ibuprofen lysinate.
    Type: Grant
    Filed: May 1, 1992
    Date of Patent: April 22, 1997
    Inventors: Ashok Katdare, Chung Y. Lui, Scott N. Kleinbart
  • Pharmaceutical tablet
    Patent number: D380825
    Type: Grant
    Filed: October 31, 1994
    Date of Patent: July 8, 1997
    Assignee: Merck & Co., Inc.
    Inventors: Kenneth A. Kramer, Ashok Katdare